Atlas Private Wealth Advisors 9 Meters Biopharma, Inc. Transaction History

Atlas Private Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$1.04 - $1.5 $5,200 - $7,500	-5,000 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$0.84 - $2.16 $29,400 - $75,600	-35,000 Reduced 87.5%	5,000 $6,000
Q4 2020 Jan 29, 2021	BUY	$0.65 - $1.11 $13,000 - $22,200	20,000 Added 100.0%	40,000 $34,000
Q3 2020 Oct 27, 2020	BUY	$0.48 - $0.84 $9,600 - $16,800	20,000 New	20,000 $16,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Atlas Private Wealth Advisors with notifications on news.